Literature DB >> 28223405

Stromal Cell Niches in the Inflamed Central Nervous System.

Natalia B Pikor1, Jovana Cupovic1, Lucas Onder1, Jennifer L Gommerman2, Burkhard Ludewig3.   

Abstract

Inflammation in the CNS must be tightly regulated to respond efficiently to infection with neurotropic pathogens. Access of immune cells to the CNS and their positioning within the tissue are controlled by stromal cells that construct the barriers of the CNS. Although the role of the endothelium in regulating the passage of leukocytes and small molecules into the CNS has been studied extensively, the contribution of fibroblastic stromal cells as portals of entry into the CNS was only recently uncovered. We review the critical immune-stimulating role of meningeal fibroblasts in promoting recruitment and retention of lymphocytes during CNS inflammation. Activated meningeal fibroblastic stromal cells have the capacity to rapidly elaborate an immune-competent niche that sustains protective immune cells entering the CNS from the draining cervical lymph node. Such stromal cell niches can ultimately foster the establishment of tertiary lymphoid tissues during chronic neuroinflammatory conditions.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Year:  2017        PMID: 28223405     DOI: 10.4049/jimmunol.1601566

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

Review 1.  Meningeal Lymphatics: From Anatomy to Central Nervous System Immune Surveillance.

Authors:  Zachary Papadopoulos; Jasmin Herz; Jonathan Kipnis
Journal:  J Immunol       Date:  2020-01-15       Impact factor: 5.422

2.  The chronically inflamed central nervous system provides niches for long-lived plasma cells.

Authors:  Karolin Pollok; Ronja Mothes; Carolin Ulbricht; Alina Liebheit; Jan David Gerken; Sylvia Uhlmann; Friedemann Paul; Raluca Niesner; Helena Radbruch; Anja Erika Hauser
Journal:  Acta Neuropathol Commun       Date:  2017-11-25       Impact factor: 7.801

3.  Features of ectopic lymphoid-like structures in human uveitis.

Authors:  Simon J Epps; Natalie Coplin; Philip J Luthert; Andrew D Dick; Sarah E Coupland; Lindsay B Nicholson
Journal:  Exp Eye Res       Date:  2019-12-23       Impact factor: 3.467

4.  LFA-1 Controls Th1 and Th17 Motility Behavior in the Inflamed Central Nervous System.

Authors:  Silvia Dusi; Stefano Angiari; Enrica Caterina Pietronigro; Nicola Lopez; Gabriele Angelini; Elena Zenaro; Vittorina Della Bianca; Gabriele Tosadori; Francesca Paris; Antonella Amoruso; Tommaso Carlucci; Gabriela Constantin; Barbara Rossi
Journal:  Front Immunol       Date:  2019-10-18       Impact factor: 7.561

Review 5.  Tertiary Lymphoid Structures in the Central Nervous System: Implications for Glioblastoma.

Authors:  Tiarne van de Walle; Alessandra Vaccaro; Mohanraj Ramachandran; Ilkka Pietilä; Magnus Essand; Anna Dimberg
Journal:  Front Immunol       Date:  2021-09-01       Impact factor: 7.561

Review 6.  Living on the Edge of the CNS: Meninges Cell Diversity in Health and Disease.

Authors:  Julia Derk; Hannah E Jones; Christina Como; Bradley Pawlikowski; Julie A Siegenthaler
Journal:  Front Cell Neurosci       Date:  2021-07-01       Impact factor: 5.505

Review 7.  Targeting senescence to delay progression of multiple sclerosis.

Authors:  Wendy Oost; Nynke Talma; Jan F Meilof; Jon D Laman
Journal:  J Mol Med (Berl)       Date:  2018-09-18       Impact factor: 4.599

8.  The Lactate Receptor HCA1 Is Present in the Choroid Plexus, the Tela Choroidea, and the Neuroepithelial Lining of the Dorsal Part of the Third Ventricle.

Authors:  Alena Hadzic; Teresa D Nguyen; Makoto Hosoyamada; Naoko H Tomioka; Linda H Bergersen; Jon Storm-Mathisen; Cecilie Morland
Journal:  Int J Mol Sci       Date:  2020-09-04       Impact factor: 5.923

9.  Targeting S100A4 with niclosamide attenuates inflammatory and profibrotic pathways in models of amyotrophic lateral sclerosis.

Authors:  Martina Milani; Eleonora Mammarella; Simona Rossi; Chiara Miele; Serena Lattante; Mario Sabatelli; Mauro Cozzolino; Nadia D'Ambrosi; Savina Apolloni
Journal:  J Neuroinflammation       Date:  2021-06-12       Impact factor: 8.322

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.